Abstract:Background : Metabolic (dysfunction)-associated fatty liver disease is the most common liver disease related to various metabolic disorders. Colorectal adenomas are related to metabolic dysregulation. Despite the proposed association between non-alcoholic fatty liver disease and colorectal adenomas, the influence of metabolic-associated fatty liver disease on colorectal adenomas has yet to be investigated. Our study investigates the relationship between metabolic-associated fatty liver disease and colorectal adenomas and evaluates the predictive value of fatty liver index for colorectal adenomas. Methods : A retrospective cross-sectional study was conducted on 650 inpatients at Qinghai Provincial People's Hospital. All participants underwent colonoscopy, abdominal ultrasound or CT, relevant laboratory tests, and physical examinations to ascertain baseline characteristics and overall health status. Multivariate logistic regression analysis examined the relationship between metabolic-associated fatty liver disease and colorectal adenomas. Lastly, the ability to identify, accuracy, and clinical applicability of predicting colorectal adenomas through fatty liver index were assessed using receiver operating characteristic curve area under the curve, calibration curve, and decision curve analysis. Result : In both the colorectal adenomas and control groups, the prevalence of metabolic-associated fatty liver disease was 62.1% and 35.7%, respectively. Multivariate analysis indicates that metabolic-associated fatty liver disease was independently correlated with an increased risk of colorectal adenomas (OR, 1.565; 95% CI, 1.057-2.319; P < 0.05). Further analysis revealed that the risk of colorectal adenomas increased with an increasing quantity of metabolic components in metabolic-associated fatty liver disease ( P trend < 0.001). The area under the curve of the fatty liver index predictive model was 0.838, with a 95% CI of 0.807-0.869. The calibration curve indicated excellent agreement, and the decision curve analysis revealed a higher net benefit. Conclusion : The risk of colorectal adenomas was associated with metabolic-associated fatty liver disease, and the risk of developing colorectal adenomas increased with the presence of more metabolic-associated fatty liver disease metabolic components. Furthermore, fatty liver index served as a predictive indicator for screening colorectal adenomas.

The Fatty Liver Index: A Simple and Accurate Predictor of Colorectal Adenoma in an Average-Risk Population

Relationship Between Colorectal Adenomatous Polyps and Non-alcoholic Fatty Liver Disease in A Physical Check-up Population

Retrospective Study of Risk Factors for Colorectal Adenomas and Non-Adenomatous Polyps

Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components

Non-alcoholic Fatty Liver Disease: an Early Mediator Predicting Metabolic Syndrome in Obese Children?

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease

Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

A Novel Model for Predicting Fatty Liver Disease by Means of an Artificial Neural Network

Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome

Fatty Liver Index and Its Association with 10-Year Atherosclerotic Cardiovascular Disease Risk: Insights from a Population-Based Cross-Sectional Study in China.

Risk for the Development of Non-Alcoholic Fatty Liver Disease: A Prospective Study.

Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study

ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population

Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver disease

Fatty liver index as an independent predictor of all-cause and disease-specific mortality

Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)

High Prevalence of Colorectal Neoplasm in Patients with Non-Alcoholic Steatohepatitis

Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People

The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients

Combining Serum Uric Acid and Fatty Liver Index to Improve Prediction Quality of Nonalcoholic Fatty Liver Disease